Skip to main content
Premium Trial:

Request an Annual Quote

Ibis Biosciences Wins $1.2M NIH Subcontract for Flu Detection Assays

NEW YORK (GenomeWeb News) - Ibis Biosciences, a subsidiary of Isis Pharmaceuticals, said yesterday that has been awarded a $1.2 million subcontract from the National Institutes of Health to study how influenza viruses are transmitted.
 
Ibis is conducting the research through a subcontract with its partner the Lovelace Respiratory Research Institute. The grant will sponsor assay development and sample characterization for viruses including the H5N1 strain, which causes avian flu.
 
Ibis will use its T5000 Biosensor System and a methodology called Triangulation Identification for the Genetic Evaluation of Risks, which it said is “a combination of genomics, mathematical modeling, mass spectrometry and molecular amplification.”
 
The expanded influenza detection assays Ibis and LRRI plan to develop will “uniquely identify and characterize influenza strains and aid in the tracking of influenza transmissions,” the company said.  

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.